Through our breadth and depth of services, we offer biotechnology and  pharmaceutical companies as well as nutraceutical companies and patient and non-profit organizations an integrated platform that encompasses all stages of the gene-to-candidate discovery process. 

Our partners include the ALS Association, Amgen, AstraZeneca, BASF, Boehringer Ingelheim, Celgene, the Cystic Fibrosis Foundation, GlaxoSmithKline, Idenix, LEO Pharma, Roche and the University of Bristol.